CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −300 | $580.16 | $174K | 328,309 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −520 | $581.52 | $302K | 327,789 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,732 | $582.79 | $1.0M | 326,057 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 62,410 | ||
| 2026-11-06 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-11-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −109 | $560.79 | $61K | 333,834 |
| 2026-11-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,005 | $561.80 | $1.1M | 331,829 |
| 2026-11-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,136 | $562.87 | $639K | 330,693 |
| 2026-11-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −870 | $563.85 | $491K | 329,823 |
| 2026-11-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,776 | $564.99 | $1.0M | 328,047 |
| 2026-11-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,742 | $565.85 | $986K | 326,305 |
| 2026-11-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,021 | $566.83 | $579K | 325,284 |
| 2026-11-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −761 | $567.64 | $432K | 324,523 |
| 2026-11-06 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $568.68 | $45K | 324,443 |
| 2026-11-06 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 71,910 | ||
| 2026-11-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $593.14 | $119K | 326,203 |
| 2026-11-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $594.51 | $166K | 325,923 |
| 2026-11-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $595.43 | $71K | 325,803 |
| 2026-11-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −306 | $596.71 | $183K | 325,497 |
| 2026-11-05 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −237 | $597.74 | $142K | 325,260 |
Page 4 of 64 · 1,267 trades